These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 20408961)

  • 21. Expanding the clinical phenotype of the mitochondrial m.13513G>A mutation with the first report of a fatal neonatal presentation.
    Van Karnebeek CD; Waters PJ; Sargent MA; Mezei MM; Wong LJ; Wang J; Stöckler-Ipsiroglu S
    Dev Med Child Neurol; 2011 Jun; 53(6):565-8. PubMed ID: 21518340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unique presentation of LHON/MELAS overlap syndrome caused by m.13046T>C in MTND5.
    Kolarova H; Liskova P; Tesarova M; Kucerova Vidrova V; Forgac M; Zamecnik J; Hansikova H; Honzik T
    Ophthalmic Genet; 2016 Dec; 37(4):419-423. PubMed ID: 26894521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-fiber analysis of mitochondrial A3243G mutation in four different phenotypes.
    Koga Y; Koga A; Iwanaga R; Akita Y; Tubone J; Matsuishi T; Takane N; Sato Y; Kato H
    Acta Neuropathol; 2000 Feb; 99(2):186-90. PubMed ID: 10672326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical, pathologic and genetic studies on mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes.
    Guo Y; Guo Z; Chen L; Zhang J; Wang W; Liu X; Ren H; Gao S
    Chin Med J (Engl); 1997 Nov; 110(11):851-5. PubMed ID: 9772417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MELAS with the mitochondrial DNA 3243 point mutation: a neuropathological study.
    Tanahashi C; Nakayama A; Yoshida M; Ito M; Mori N; Hashizume Y
    Acta Neuropathol; 2000 Jan; 99(1):31-8. PubMed ID: 10651025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exclusive affection of the brain in m.4450G>A carriers rather suggests Leigh syndrome than MELAS.
    Finsterer J
    Brain Dev; 2019 Sep; 41(8):741. PubMed ID: 30952460
    [No Abstract]   [Full Text] [Related]  

  • 27. MELAS syndrome, cardiomyopathy, rhabdomyolysis, and autism associated with the A3260G mitochondrial DNA mutation.
    Connolly BS; Feigenbaum AS; Robinson BH; Dipchand AI; Simon DK; Tarnopolsky MA
    Biochem Biophys Res Commun; 2010 Nov; 402(2):443-7. PubMed ID: 20965148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TALEN-mediated shift of mitochondrial DNA heteroplasmy in MELAS-iPSCs with m.13513G>A mutation.
    Yahata N; Matsumoto Y; Omi M; Yamamoto N; Hata R
    Sci Rep; 2017 Nov; 7(1):15557. PubMed ID: 29138463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations in ND subunits of complex I are an important genetic cause of childhood mitochondrial encephalopathies.
    Lim BC; Park JD; Hwang H; Kim KJ; Hwang YS; Chae JH; Cheon JE; Kim IO; Lee R; Moon HK
    J Child Neurol; 2009 Jul; 24(7):828-32. PubMed ID: 19617458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infantile encephalopathy associated with the MELAS A3243G mutation.
    Sue CM; Bruno C; Andreu AL; Cargan A; Mendell JR; Tsao CY; Luquette M; Paolicchi J; Shanske S; DiMauro S; De Vivo DC
    J Pediatr; 1999 Jun; 134(6):696-700. PubMed ID: 10356136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinctive distribution of brain volume reductions in MELAS and mitochondrial DNA A3243G mutation carriers: A voxel-based morphometric study.
    Tsujikawa K; Senda J; Yasui K; Hasegawa Y; Hoshiyama M; Katsuno M; Sobue G
    Mitochondrion; 2016 Sep; 30():229-35. PubMed ID: 27558483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical features of MELAS and its relation with A3243G gene point mutation.
    Zhang J; Guo J; Fang W; Jun Q; Shi K
    Int J Clin Exp Pathol; 2015; 8(10):13411-5. PubMed ID: 26722549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MELAS: A Multigenerational Impact of the MTTL1 A3243G MELAS Mutation.
    Prasad M; Narayan B; Prasad AN; Rupar CA; Levin S; Kronick J; Ramsay D; Tay KY; Prasad C
    Can J Neurol Sci; 2014 Mar; 41(2):210-9. PubMed ID: 24534033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MELAS: clinical phenotype and morphological brain abnormalities.
    Sparaco M; Simonati A; Cavallaro T; Bartolomei L; Grauso M; Piscioli F; Morelli L; Rizzuto N
    Acta Neuropathol; 2003 Sep; 106(3):202-12. PubMed ID: 12910360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical features of A3243G mitochondrial tRNA mutation.
    Chae JH; Hwang H; Lim BC; Cheong HI; Hwang YS; Kim KJ
    Brain Dev; 2004 Oct; 26(7):459-62. PubMed ID: 15351082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency of MELAS main mutation in a phenotype-targeted young ischemic stroke patient population.
    Tatlisumak T; Putaala J; Innilä M; Enzinger C; Metso TM; Curtze S; von Sarnowski B; Amaral-Silva A; Jungehulsing GJ; Tanislav C; Thijs V; Rolfs A; Norrving B; Fazekas F; Suomalainen A; Kolodny EH
    J Neurol; 2016 Feb; 263(2):257-262. PubMed ID: 26566914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disruption of endothelial tight junctions in a patient with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS).
    Matsuzaki M; Takahashi R; Nakayama T; Shishikura K; Suzuki H; Hirayama Y; Osawa M; Oda H
    Neuropediatrics; 2010 Aug; 41(2):72-4. PubMed ID: 20799154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes/Leigh Overlap Syndrome Due to Variant m.13513G>A in MT-ND5.
    Finsterer J; Hayman J
    Cureus; 2022 May; 14(5):e24746. PubMed ID: 35677009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mitochondrial 13513G>A mutation is associated with Leigh disease phenotypes independent of complex I deficiency in muscle.
    Brautbar A; Wang J; Abdenur JE; Chang RC; Thomas JA; Grebe TA; Lim C; Weng SW; Graham BH; Wong LJ
    Mol Genet Metab; 2008 Aug; 94(4):485-490. PubMed ID: 18495510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An autopsy case of mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) with a point mutation of mitochondrial DNA.
    Terauchi A; Tamagawa K; Morimatsu Y; Kobayashi M; Sano T; Yoda S
    Brain Dev; 1996; 18(3):224-9. PubMed ID: 8836506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.